Get the tools used by (smart)2 investors.

EBITDA Margin for REMSleep Holdings Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

RMSL: REMSleep Holdings Inc

REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients w...

0.01 USD
Price
USD
Fair Value
Upside
0.01 - 0.03
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on REMSleep Holdings Inc's EBITDA Margin:

Dec 2015Dec 2017Dec 2019Dec 2021Dec 2023-800.0%-600.0%-400.0%-200.0%0.0%

Performance Summary
  • REMSleep's latest twelve months ebitda margin is -1,206.9%
  • REMSleep's ebitda margin hit its 5-year low in December 2023 of -819.5%.
  • REMSleep's ebitda margin decreased in 2023 (-819.5%, +127.2%).

How does REMSleep Holdings's EBITDA Margin benchmark against competitors?

Hide this widget

We've identified the following companies as similar to REMSleep Holdings Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: EBITDA Margin

Hide this widget
ebitda_margin
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EBITDA Margin in the efficiency category include:

View Full List

Search for metric or datapoint

EBITDA Margin

Earnings before interest, taxes, depreciation and amortization (EBITDA) expressed as a percent of revenue.

Definition of EBITDA Margin

Hide this widget

The ebitda margin measures a company’s ebitda as a percentage of the revenue. The formula to calculate ebitda margin and an example calculation for REMSleep’s trailing twelve months is outlined below:

EBITDA Margin  = EBITDA / Total Revenue
−1,206.9% = -1.571 M  /  130.191 T

The tables below summarizes REMSleep’s performance over the last five years:

Fiscal YearEBITDARevenueMargin
2019-12-31-2.324 MNANA
2020-12-31-420.691 TNANA
2021-12-31-368.127 TNANA
2022-12-31-1.157 M320.719 T−360.7%
2023-12-31-1.669 M203.718 T−819.5%

The tables below summarizes REMSleep’s performance over the last four quarters:

Quarter EndingEBITDARevenueMargin
2023-12-31-1.02 M7.456 T−13,674.7%
2024-03-31-96.654 T57.881 T−167.0%
2024-06-30-270.781 T27.594 T−981.3%
2024-09-30-184.311 T37.26 T−494.7%

You can read more about EBITDA here.


Click the link below to download a spreadsheet with an example EBITDA Margin calculation for REMSleep Holdings Inc below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-45,551.4%-30,551.4%-15,551.4%1,059.3%0200400600800

The chart above depicts the distribution of ebitda margin for companies operating in the Healthcare sector in the Developed economic region. Over 1,920 companies were considered in this analysis, and 1,848 had meaningful values. The average ebitda margin of companies in the sector is -1,035.5% with a standard deviation of 4,163.8%.

REMSleep Holdings Inc's EBITDA Margin of -1,206.9% ranks in the 13.1% percentile for the sector. The following table provides additional summary stats:

EBITDA Margin In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,924
Included Constituents1,848
Min-46,520.8%
Max58.4%
Median-9.5%
Mean-1,035.5%
Standard Deviation4,163.8%

You can find companies with similar ebitda margin using this stock screener.

All rights reserved. Terms Of Use